Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ari Raphael
29 years of experience
accreditations :
Clinic is certified :
Why choose Israel for chemotherapy for lung cancer?
Access advanced chemotherapy for lung cancer solutions in trusted clinics from $600.
| Israel | Turkey | Austria | |
| Chemotherapy for lung cancer | from $600 | from $850 | ≈ $4,500 |
Day 1
Day 2
Day 3 - Treatment Day
Day 4 - Post-Treatment
Week 1-2
Week 3-4 - Rehabilitation
Please note that the timeline and process might vary based on individual patient"s condition and response to treatment.
As the leading global medical tourism platform, we provide information about Chemotherapy for lung cancer and medical centers in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services for Chemotherapy for lung cancer in Israel.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic for Chemotherapy for lung cancer in Israel — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers in Israel just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com for Chemotherapy for lung cancer in Israel, please feel free to contact us at marketing@bookimed.com.
Dr. Ari Raphael leads groundbreaking clinical trials in lung cancer treatment at Sourasky Medical Center, focusing on innovative genomic approaches.
Prof. Merimsky heads the Lung Cancer Service at Sourasky Medical Center with over 41 years of specialized oncology experience.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.
Chemo uses cancer drugs to kill or stop the growth of cancer cells in the lungs.
Chemotherapy for lung cancer in Israel primarily serves as a systemic treatment for small cell lung cancer and advanced non-small cell lung cancer. Clinics like Sourasky Medical Center and Sheba Medical Center utilize platinum-based regimens to destroy metastatic cells, shrink tumors, and extend patient survival.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center integrate genomic profiling into standard chemotherapy planning. By using Foundation One CDx testing, doctors can identify if a patient needs targeted therapy first. This prevents unnecessary chemotherapy sessions for those with specific genetic mutations like EGFR.
Patient Consensus: Patients emphasize verifying your specific cancer subtype, such as NSCLC or SCLC, before starting treatment. Many recommend discussing biomarker testing to see if combining chemotherapy with immunotherapy could improve your outcome.
Chemotherapy is combined with surgery, radiation, immunotherapy, or targeted therapy to increase survival rates and prevent recurrence. In Israel, clinicians use neoadjuvant chemotherapy to shrink tumors before surgery or adjuvant therapy to eliminate microscopic cells, often integrating personalized genomic profiling to select specific drug combinations.
Bookimed Expert Insight: Israeli specialists like Dr. Ari Raphael at Sourasky Medical Center leverage advanced genomic profiling to personalize combinations. Data shows that adding chemotherapy to targeted therapies like osimertinib can delay cancer progression for an extra year compared to using targeted drugs alone. High-volume centers such as Sourasky treat 40,000 cancer patients annually, providing immense data for these precise protocols.
Patient Consensus: Many patients emphasize getting a second opinion on mutation status before starting, as markers like EGFR or PD-L1 determine if chemotherapy is used alone or paired with immunotherapy.
Chemotherapy targets rapidly dividing cells, often affecting the digestive tract, hair follicles, and bone marrow. Common symptoms include fatigue, nausea, and hair loss. Israeli oncology centers manage these through personalized genomic profiling and advanced supportive therapies to minimize discomfort and improve treatment tolerance.
Bookimed Expert Insight: Leading Israeli centers like Sourasky Medical Center utilize Foundation One CDx genomic profiling to select targeted agents. This precision approach often replaces or supplements traditional chemotherapy. It specifically targets cancer mutations while sparing healthy tissue, which significantly reduces the severity of systemic side effects compared to standard treatments.
Patient Consensus: Many patients emphasize that taking anti-nausea medication and steroids early in the morning prevents the `crash` and sleep disruption. Maintaining hydration through soups or ice cream is a practical way to manage appetite loss and dehydration.
Targeted therapy replaces chemotherapy as a first-line treatment for lung cancer when specific genetic mutations like EGFR, ALK, or ROS1 are confirmed. Specialized facilities in Israel, including Sourasky Medical Center, utilize genomic profiling to identify these markers, allowing for high-precision treatment that spares healthy cells.
Bookimed Expert Insight: Israeli oncology centers lead in molecular medicine by integrating liquid biopsies and genomic profiling directly into the initial consultation. Dr. Ari Raphael at Sourasky even moderates a Molecular Tumor Board specifically to match patients with the latest targeted drugs. This infrastructure means patients often transition from diagnosis to targeted treatment much faster than in systems relying on traditional tissue biopsies alone.
Patient Consensus: Patients emphasize that quality of life improves significantly on targeted drugs compared to chemotherapy. Many stress the vital importance of completing comprehensive biomarker testing before agreeing to any standard chemo protocol.
Israel offers advanced chemotherapy types including platinum-based combinations, hyperthermic intraperitoneal chemotherapy (HIPEC), and chemoembolization. Oncology centers like Sourasky and Sheba integrate these with immunotherapy (Keytruda) and targeted therapies. Precision is ensured through Next-Generation Sequencing (NGS) and Foundation One CDx genetic testing.
Bookimed Expert Insight: Israeli oncology stands out by treating over 40,000 patients annually at Sourasky Medical Center alone. Data shows clinics here prioritize JCI-accredited precision medicine. Senior experts like Dr. Ari Raphael often lead national genomic initiatives. This high volume leads to refined protocols in combined therapy.
Patient Consensus: Patients value how Israeli doctors integrate immunotherapy like Keytruda directly with standard platinum-based regimens. Many highlight that molecular testing for mutations like EGFR or ALK is standard before starting treatment.
Clinical trials in Israel provide early access to experimental lung cancer therapies like immunotherapy and gene therapy. These government-authorized studies occur at major JCI-accredited centers. Many focus on molecular profiling and nanoparticle technology to treat advanced or treatment-resistant cases years before global availability.
Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba prioritize translational research. Dr. Ari Raphael at Sourasky specifically leads Phase 1 and 3 trials focusing on liquid biopsies. This allows patients to access experimental protocols that precisely monitor drug resistance during treatment in real-time.
Patient Consensus: Patients value how trials offer a strategic pathway to cutting-edge antibody-drug conjugates when standard care fails. Many emphasize the importance of verifying trial availability for specific lung cancer subtypes through official clinical databases before traveling.
Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.
Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.
Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.
Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.
Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.
Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.
Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.
Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.
Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.
Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.
Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.
Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.
International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.
Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.
Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.
A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.
Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.
Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.
Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.
Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.
Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.
Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.
Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.
Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.
Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.
Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.
Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.
Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.
Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.
Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.
International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.
Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.
Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.